Target intelligence / Profile preview

CAPZA1 pseudogene 1 (CAPZA1P1)

Target
CAPZA1P1
Molecular classification
Other (Pseudogene)
01

Overview

CAPZA1P1 refers to a pseudogene sequence related to the "Capping actin protein of muscle Z-line subunit alpha 1" (CAPZA1). Pseudogenes like CAPZA1P1 are genomic DNA sequences similar to normal genes but are non-functional due to mutations or lack of regulatory elements. They do not produce functional protein products and are not considered therapeutic, diagnostic, or pharmacological targets. CAPZA1 (the parental gene) encodes a protein involved in actin filament dynamics and cell structure regulation, but CAPZA1P1 itself does not have an established biological function, disease association, or relevance as a drug target. While CAPZA1 is a protein-coding gene involved in actin filament regulation and linked to some myopathies and cellular processes, CAPZA1P1 is a probable annotation for a repetitive or homologous, non-coding sequence, with no evidence for coding potential, biological function, or clinical significance. If you were seeking information about the canonical protein-coding gene, refer to "Capping actin protein of muscle Z-line subunit alpha 1" (CAPZA1), not CAPZA1P1. CAPZA1 pseudogene 1 (CAPZA1P1) is not a therapeutic target, not associated with biological or pharmacological function, and should be distinguished from the functional CAPZA1 gene, which encodes an actin-binding protein critical for cytoskeletal dynamics.

Other names
capping protein (actin filament) muscle Z-line, alpha 1 pseudogeneF-actin-capping protein subunit alpha-1-like proteincapping actin protein of muscle Z-line subunit alpha 1 pseudogene

Beyond the preview

Go deeper on CAPZA1 pseudogene 1 (CAPZA1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAPZA1 pseudogene 1 (CAPZA1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call